Slideshows Images Quizzes

Kenalog 10 Injection

Last reviewed on RxList: 12/5/2016
Kenalog 10 Injection Side Effects Center

Last reviewed on RxList 9/23/2016

Kenalog 10 Injection (triamcinolone acetonide) is a steroid injected into the joint space to treat inflammation of the joints or tendons to treat arthritis, bursitis, or epicondylitis (tennis elbow). Kenalog 10 is usually given in these conditions as a short-term treatment of a severe or aggravated episode. Kenalog 10 Injection is also injected into soft tissues of the body to treat certain skin disorders caused by autoimmune conditions such as lupus, psoriasis, lichen planus, and others. Kenalog 10 Injection is available in generic form. Common side effects of Kenalog 10 include:

  • nausea,
  • bloating,
  • appetite changes,
  • stomach or side pain,
  • stomach upset,
  • headache,
  • sleep problems (insomnia),
  • acne,
  • scaling or other skin changes,
  • slow-healing wounds,
  • thinning hair,
  • bruising or swelling,
  • sweating more than usual,
  • irregular menstrual periods,
  • redness or pain at the injection site,
  • dizziness, or
  • weight gain.

Dosage for Kenalog 10 Injection is individualized based on the condition and patient response. Kenalog 10 Injection may interact with aminoglutethimide, birth control pills, hormone replacement therapy, blood thinners, cyclosporine, digoxin, insulin or diabetes medications you take by mouth, isoniazid, rifampin, seizure medication, antibiotics, aspirin, or other NSAIDs (nonsteroidal anti-inflammatory drugs). Tell your doctor all medications you are taking. Kenalog 10 Injection should be used during pregnancy only if prescribed. This medication may be harmful to a fetus. Infants born to mothers who have received corticosteroids during pregnancy should be observed for signs of hypoadrenalism. This medication can pass into breast milk and may harm a nursing baby. Consult your doctor before breastfeeding.

Our Kenalog 10 Injection (triamcinolone acetonide) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Kenalog 10 Injection Consumer Information

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have a serious side effect such as:

  • fast, slow, or uneven heart rate;
  • feeling short of breath, even with mild exertion;
  • swelling, rapid weight gain;
  • dangerously high blood pressure (severe headache, buzzing in your ears, anxiety, confusion, chest pain);
  • problems with your vision;
  • eye swelling, redness, discomfort, or drainage (may be signs of infection);
  • severe depression, changes in mood or behavior;
  • seizure (convulsions); or
  • muscle pain, tenderness, or weakness.

Less serious side effects may include:

  • nausea, bloating, appetite changes;
  • stomach or side pain;
  • headache, sleep problems (insomnia);
  • acne, scaling, or other skin changes;
  • a wound that is slow to heal;
  • thinning hair;
  • bruising or swelling;
  • sweating more than usual; or
  • irregular menstrual periods.

This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.

Read the entire detailed patient monograph for Kenalog 10 Injection (Triamcinolone Acetonide Injectable Suspension)

Kenalog 10 Injection Professional Information

SIDE EFFECTS

(listed alphabetically under each subsection)

The following adverse reactions may be associated with corticosteroid therapy:

Allergic reactions: Anaphylactoid reaction, anaphylaxis including anaphylactic reactions and anaphylactic shock, angioedema.

Cardiovascular: Bradycardia, cardiac arrest, cardiac arrhythmias, cardiac enlargement, circulatory collapse, congestive heart failure, fat embolism, hypertension, hypertrophic cardiomyopathy in premature infants, myocardial rupture following recent myocardial infarction (see WARNINGS), pulmonary edema, syncope, tachycardia, thromboembolism, thrombophlebitis, vasculitis.

Dermatologic: Acne, allergic dermatitis, cutaneous and subcutaneous atrophy, dry scaly skin, ecchymoses and petechiae, edema, erythema, hyperpigmentation, hypopigmentation, impaired wound healing, increased sweating, lupus erythematosus-like lesions, purpura, rash, sterile abscess, striae, suppressed reactions to skin tests, thin fragile skin, thinning scalp hair, urticaria.

Endocrine: Decreased carbohydrate and glucose tolerance, development of cushingoid state, glycosuria, hirsutism, hypertrichosis, increased requirements for insulin or oral hypoglycemic agents in diabetes, manifestations of latent diabetes mellitus, menstrual irregularities, secondary adrenocortical and pituitary unresponsiveness (particularly in times of stress, as in trauma, surgery, or illness), suppression of growth in pediatric patients.

Fluid and electrolyte disturbances: Congestive heart failure in susceptible patients, fluid retention, hypokalemic alkalosis, potassium loss, sodium retention.

Gastrointestinal: Abdominal distention, bowel/bladder dysfunction (after intrathecal administration [see WARNINGS: Neurologic]), elevation in serum liver enzyme levels (usually reversible upon discontinuation), hepatomegaly, increased appetite, nausea, pancreatitis, peptic ulcer with possible perforation and hemorrhage, perforation of the small and large intestine (particularly in patients with inflammatory bowel disease), ulcerative esophagitis.

Metabolic: Negative nitrogen balance due to protein catabolism.

Musculoskeletal: Aseptic necrosis of femoral and humeral heads, calcinosis (following intra- articular or intralesional use), Charcot-like arthropathy, loss of muscle mass, muscle weakness, osteoporosis, pathologic fracture of long bones, post injection flare (following intra-articular use), steroid myopathy, tendon rupture, vertebral compression fractures.

Neurologic/Psychiatric: Convulsions, depression, emotional instability, euphoria, headache, increased intracranial pressure with papilledema (pseudotumor cerebri) usually following discontinuation of treatment, insomnia, mood swings, neuritis, neuropathy, paresthesia, personality changes, psychiatric disorders, vertigo. Arachnoiditis, meningitis, paraparesis/paraplegia, and sensory disturbances have occurred after intrathecal administration.

Spinal cord infarction, paraplegia, quadriplegia, cortical blindness, and stroke (including brainstem) have been reported after epidural administration of corticosteroids (see WARNINGS: Neurologic).

Ophthalmic: Exophthalmos, glaucoma, increased intraocular pressure, posterior subcapsular cataracts, rare instances of blindness associated with periocular injections.

Other: Abnormal fat deposits, decreased resistance to infection, hiccups, increased or decreased motility and number of spermatozoa, malaise, moon face, weight gain.

Read the entire FDA prescribing information for Kenalog 10 Injection (Triamcinolone Acetonide Injectable Suspension)

Related Resources for Kenalog 10 Injection

Read the Kenalog 10 Injection User Reviews »

© Kenalog 10 Injection Patient Information is supplied by Cerner Multum, Inc. and Kenalog 10 Injection Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.

Health Solutions From Our Sponsors